share_log

Eledon Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Robinson James A. Jr.

SEC announcement ·  Oct 2, 2023 17:51
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more